Search Results - "PIIRONEN, Timo"

Refine Results
  1. 1

    Reproducibility and Accuracy of Measurements of Free and Total Prostate-Specific Antigen in Serum vs Plasma after Long-Term Storage at -20 {degrees}C by Ulmert, David, Becker, Charlotte, Nilsson, Jan-Ake, Piironen, Timo, Bjork, Thomas, Hugosson, Jonas, Berglund, Goran, Lilja, Hans

    Published in Clinical chemistry (Baltimore, Md.) (01-02-2006)
    “…Abstract Background: Long-term frozen storage may alter the results of prostate-specific antigen (PSA) measurements, mainly because of degradation of free PSA…”
    Get full text
    Journal Article
  2. 2

    Specific Immunoassays for Detection of Intact and Cleaved Forms of the Urokinase Receptor by Piironen, Timo, Laursen, Birgitte, Pass, Jesper, List, Karin, Gardsvoll, Henrik, Ploug, Michael, Dano, Keld, Hoyer-Hansen, Gunilla

    Published in Clinical chemistry (Baltimore, Md.) (01-11-2004)
    “…The cell surface receptor (uPAR) for urokinase plasminogen activator (uPA) is a strong prognostic marker in several types of cancer. uPA cleaves the…”
    Get full text
    Journal Article
  3. 3

    Enhanced Discrimination of Benign from Malignant Prostatic Disease by Selective Measurements of Cleaved Forms of Urokinase Receptor in Serum by Piironen, Timo, Haese, Alexander, Huland, Hartwig, Steuber, Thomas, Christensen, Ib Jarle, Brunner, Nils, Dano, Keld, Hoyer-Hansen, Gunilla, Lilja, Hans

    Published in Clinical chemistry (Baltimore, Md.) (01-05-2006)
    “…Early detection of prostate cancer (PCa) centers on measurements of prostate-specific antigen (PSA), but current testing practices suffer from lack of…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Comparison of analysis of the different prostate-specific antigen forms in serum for detection of clinically localized prostate cancer by BjÖrk, Thomas, Piironen, Timo, Pettersson, Kim, Lövgren, Timo, Stenman, Ulf-Hkan, Oesterling, Joseph E., Abrahamsson, Per-Anders, Lilja, Hans

    Published in Urology (Ridgewood, N.J.) (01-12-1996)
    “…To compare different forms and ratios of serum prostate-specific antigen (PSA) to determine which form or ratio provides optimal diagnostic specificity and…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Biological Effects of Anti-Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Antibody Formation in Patients Treated With GM-CSF (Sargramostim) as Adjuvant Therapy of Melanoma by Spitler, Lynn E, Cao, Huynh, Piironen, Timo, Whiteside, Theresa L, Weber, Robert W, Cruickshank, Scott

    Published in American journal of clinical oncology (01-04-2017)
    “…We investigated the development of binding and neutralizing antibodies to granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients receiving…”
    Get full text
    Journal Article
  10. 10

    Addressing the challenges of biomarker calibration standards in ligand-binding assays: a European Bioanalysis Forum perspective by Kunz, Ulrich, Goodman, Joanne, Loevgren, Ulf, Piironen, Timo, Elsby, Karen, Robinson, Paul, Pihl, Susanne, Versteilen, Amanda, Companjen, Arjen, Fjording, Marianne Scheel, Timmerman, Philip

    Published in Bioanalysis (01-10-2017)
    “…The analysis of biomarkers by ligand-binding assays offers significant challenges compared with the bioanalysis of small and large molecule drugs. The presence…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long-term storage at -20 degrees C by Ulmert, David, Becker, Charlotte, Nilsson, Jan-Ake, Piironen, Timo, Björk, Thomas, Hugosson, Jonas, Berglund, Göran, Lilja, Hans

    Published in Clinical chemistry (Baltimore, Md.) (01-02-2006)
    “…Long-term frozen storage may alter the results of prostate-specific antigen (PSA) measurements, mainly because of degradation of free PSA (fPSA) in vitro. We…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater by Becker, Charlotte, Piironen, Timo, Pettersson, Kim, Hugosson, Jonas, Lilja, Hans

    Published in Urology (Ridgewood, N.J.) (01-05-2000)
    “…Objectives. To investigate the clinical value of human glandular kallikrein 2 (hK2) compared with free (f) and total (t) prostate-specific antigen (PSA) in the…”
    Get full text
    Journal Article
  15. 15

    Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml by Haese, Alexander, Graefen, Markus, Steuber, Thomas, Becker, Charlotte, Pettersson, Kim, Piironen, Timo, Noldus, Joachim, Huland, Hartwig, Lilja, Hans

    Published in The Prostate (01-10-2001)
    “…Background We measured serum levels of human glandular kallikrein 2 (hK2) in patients treated with radical retropubic prostatectomy (rrP) for clinically…”
    Get full text
    Journal Article
  16. 16

    Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios by Oesterling, J E, Jacobsen, S J, Klee, G G, Pettersson, K, Piironen, T, Abrahamsson, P A, Stenman, U H, Dowell, B, Lövgren, T, Lilja, H

    Published in The Journal of urology (01-09-1995)
    “…Prostate specific antigen (PSA) exists in the serum in several molecular forms that can be measured by immunodetectable assays: free PSA, PSA complexed to…”
    Get more information
    Journal Article
  17. 17

    In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to α1-antichymotrypsin in blood samples by Piironen, Timo, Pettersson, Kim, Suonpää, Mikko, Stenman, Ulf-Hkan, Oesterling, Joseph E., Lövgren, Timo, Lilja, Hans

    Published in Urology (Ridgewood, N.J.) (01-12-1996)
    “…Objectives. To study the in vitro stability of free and complexed forms of prostate specific antigen (PSA) in blood samples in order to establish guidelines…”
    Get full text
    Journal Article
  18. 18

    Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum by Mitrunen, K, Pettersson, K, Piironen, T, Björk, T, Lilja, H, Lövgren, T

    Published in Clinical chemistry (Baltimore, Md.) (01-08-1995)
    “…We developed a simple one-step dual-label immunoassay for simultaneous measurement of the free, noncomplexed form of prostate-specific antigen (PSA) and total…”
    Get more information
    Journal Article
  19. 19

    Soluble Urokinase Receptor Levels in Plasma During 5 Years of Highly Active Antiretroviral Therapy in HIV-1–Infected Patients by Ostrowski, Sisse R, Katzenstein, Terese L, Piironen, Timo, Gerstoft, Jan, Pedersen, Bente K, Ullum, Henrik

    “…High blood levels of the soluble urokinase receptor (suPAR) strongly predict increased mortality in human immunodeficiency virus-1 (HIV-1)–infected patients…”
    Get full text
    Journal Article
  20. 20

    Production and Characterization of Novel Anti-Prostate-specific Antigen (PSA) Monoclonal Antibodies That Do Not Detect Internally Cleaved Lys145-Lys146 Inactive PSA by Nurmikko, Pauliina, Vaisanen, Ville, Piironen, Timo, Lindgren, Sari, Lilja, Hans, Pettersson, Kim

    Published in Clinical chemistry (Baltimore, Md.) (01-10-2000)
    “…The nature of free, uncomplexed prostate-specific antigen (PSA) in the circulation is still unknown. In this study, we developed novel anti-PSA antibodies…”
    Get full text
    Journal Article